An agency scientist who accused the Centers for Disease Control and Prevention of suppressing disagreements over the accuracy of a diagnostic test obtains whistleblower protection.
It has been said that the journey of a thousand miles begins with a single step. Functional genomicists took that proverbial step earlier this month when a group led by Erich Wanker, of Berlin?s Max Delbruck Center for Molecular Medicine, reported the first yeast two-hybrid-derived human interactome (or protein-protein interaction) network in the September 1 online issue of Cell. Wanker was one of three researchers working on a first draft human interactome identified by Alison McCook in our
September 13, 2005|